Identification of PCPE-2 as the endogenous specific inhibitor of human BMP-1/tolloid-like proteinases - Inria - Institut national de recherche en sciences et technologies du numérique Accéder directement au contenu
Article Dans Une Revue Nature Communications Année : 2023

Identification of PCPE-2 as the endogenous specific inhibitor of human BMP-1/tolloid-like proteinases

Svenja Kleiser
Alexander Nyström

Résumé

AbstractBMP-1/tolloid-like proteinases (BTPs) are major players in tissue morphogenesis, growth and repair. They act by promoting the deposition of structural extracellular matrix proteins and by controlling the activity of matricellular proteins and TGF-β superfamily growth factors. They have also been implicated in several pathological conditions such as fibrosis, cancer, metabolic disorders and bone diseases. Despite this broad range of pathophysiological functions, the putative existence of a specific endogenous inhibitor capable of controlling their activities could never be confirmed. Here, we show that procollagen C-proteinase enhancer-2 (PCPE-2), a protein previously reported to bind fibrillar collagens and to promote their BTP-dependent maturation, is primarily a potent and specific inhibitor of BTPs which can counteract their proteolytic activities through direct binding. PCPE-2 therefore differs from the cognate PCPE-1 protein and extends the possibilities to fine-tune BTP activities, both in physiological conditions and in therapeutic settings.
Fichier principal
Vignette du fichier
Identification of PCPE-2.pdf (5.73 Mo) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

hal-04350568 , version 1 (17-01-2024)

Licence

Paternité

Identifiants

Citer

Sandrine Vadon-Le Goff, Agnès Tessier, Manon Napoli, Cindy Dieryckx, Julien Bauer, et al.. Identification of PCPE-2 as the endogenous specific inhibitor of human BMP-1/tolloid-like proteinases. Nature Communications, 2023, 14 (1), ⟨10.1038/s41467-023-43401-0⟩. ⟨hal-04350568⟩
54 Consultations
6 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More